Hollow mesoporous organic silicon composite nanomaterial with reverse contrast magnetic resonance imaging and drug controlled release functions and preparation method of hollow mesoporous organic silicon composite nanomaterial
Patent Information
- Authority / Receiving Office
- CN ยท China
- Current Assignee / Owner
- SOUTHERN MEDICAL UNIVERSITY
- Publication Date
- 2021-07-20
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of biomedical materials, in particular to a hollow mesoporous organosilicon composite nanomaterial with functions of reverse contrast magnetic resonance imaging and drug controlled release and a preparation method thereof. Background technique
[0002] Tumor is a disease with high morbidity and mortality. Although various anti-tumor methods have been developed, chemotherapy is still the most widely used treatment for tumors. Conventional cancer chemotherapy usually leads to severe systemic toxicity under the action of highly toxic drugs, and at the same time, the efficacy of tumor drugs is also greatly reduced. In fact, strong toxic side effects and low chemotherapy effect have become one of the main causes of death of cancer patients. Therefore, the construction of an ideal drug-loading system must satisfy the ability to deliver therapeutic drugs during the systemic circulation without premature leakage, a...